Effect of chronic mild stress on hippocampal transcriptome in mice selected for high and low stress-induced analgesia and displaying different emotional behaviors

European Neuropsychopharmacology

Volumn 21, Issue 1, 2011, Pages 45-62

  Lisowski, Pawel ^a   Juszczak, Grzegorz R ^a   Goscik, Joanna ^b   Wieczorek, Marek ^c   Zwierzchowski, Lech ^a   Swiergiel, Artur H ^a,d  

^a INSTITUTE OF GENETICS AND ANIMAL BREEDING   (Poland)

^b BIALYSTOK UNIVERSITY OF TECHNOLOGY   (Poland)

^c UNIVERSITY OF LODZ   (Poland)

^d UNIVERSITY OF GDA SK   (Poland)

Author keywords

Analgesia; Chronic stress; Depression; Gene expression; Hippocampus; Mice; Microarrays; Nociception; Pain

Indexed keywords

CHOLECYSTOKININ RECEPTOR; CHOLINERGIC RECEPTOR; GLUCOCORTICOID RECEPTOR; GLUTAMATE TRANSPORTER; THYROID HORMONE RECEPTOR; TRANSCRIPTOME;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CHROMATIN; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; EMOTION; ENVIRONMENTAL FACTOR; EPIGENETICS; GENETIC SUSCEPTIBILITY; GENOTYPE; HIPPOCAMPUS; MALE; MOOD; MOOD DISORDER; MOUSE; MOUSE STRAIN; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL;

ANALGESIA; ANIMALS; ANTIDEPRESSIVE AGENTS; APOPTOSIS; BEHAVIOR, ANIMAL; CELL DIFFERENTIATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; DEPRESSION; DISEASE MODELS, ANIMAL; EPIGENESIS, GENETIC; GENE EXPRESSION; GENE EXPRESSION PROFILING; HIPPOCAMPUS; ION CHANNELS; MALE; MICE; NEUROGENESIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; STRESS, PSYCHOLOGICAL; TIME FACTORS;

EID: 78650676921     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2010.08.004     Document Type: Article

References (77)

1. Andre J., Zeau B., Pohl M., Cesselin F., Benoliel J.J., Becker C. Involvement of cholecystokininergic systems in anxiety-induced hyperalgesia in male rats: behavioral and biochemical studies. J. Neurosci. 2005, 25:7896-7904.
2. Bazan N.G., Lukiw W.J. Cyclooxygenase-2 and presenilin-1 gene expression induced by interleukin-1beta and amyloid beta 42 peptide is potentiated by hypoxia in primary human neural cells. J. Biol. Chem. 2002, 277:30359-30367.
3. Beck S.G., Choi K.C., List T.J., Okuhara D.Y., Birnsteil S. Corticosterone alters 5-HT1A receptor-mediated hyperpolarization in area CA1 hippocampal pyramidal neurons. Neuropsychopharmacology 1996, 14:27-33.
4. Becker C., Zeau B., Rivat C., Blugeot A., Hamon M., Benoliel J.J. Repeated social defeat-induced depression-like behavioral and biological alterations in rats: involvement of cholecystokinin. Mol. Psychiatry 2008, 13:1079-1092.
5. Błaszczyk J.W., Tajchert K., Lapo I., Sadowski B. Acoustic startle and open-field behavior in mice bred for magnitude of swim analgesia. Physiol. Behav. 2000, 70:471-476.
6. Charney D.S., Manji H.K. Life stress, genes, and depression: multiple pathways lead to increased risk and new opportunities for intervention. Sci. STKE 2004:re5 2004.
7. Chen Y., Sharma R.P., Costa R.H., Costa E., Grayson D.R. On the epigenetic regulation of the human reelin promoter. Nucleic Acids Res. 2002, 30:2930-2939.
8. de Kloet E.R., Joels M., Holsboer F. Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 2005, 6:463-475.
9. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Arch. Gen. Psychiatry 1997, 54:597-606.
10. Dunn A.J., Swiergiel A.H., Zhang H., Quan N. Reduced ingestion of sweetened milk induced by interleukin-1 and lipopolysaccharide is associated with induction of cyclooxygenase-2 in brain endothelia. Neuroimmunomodulation 2006, 13:96-114.
11. Ebert A.D., Chen F., He X., Cryns V.L., Bohn M.C. A tetracycline-regulated adenovirus encoding dominant-negative caspase-9 is regulated in rat brain and protects against neurotoxin-induced cell death in vitro, but not in vivo. Exp. Neurol. 2005, 191(Suppl 1):S80-S94.
12. Ejchel-Cohen T.F., Wood G.E., Wang J.F., Barlow K., Nobrega J.N., BSM, Trevor Young L. Chronic restraint stress decreases the expression of glutathione S-transferase pi2 in the mouse hippocampus. Brain Res. 2006, 1090:156-162.
13. Elenkov I.J., Chrousos G.P. Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibility to disease. Trends Endocrinol. Metab. 1999, 10:359-368.
14. Ge Y.W., Lahiri D.K. Regulation of promoter activity of the APP gene by cytokines and growth factors: implications in Alzheimer's disease. Ann. NY Acad. Sci. 2002, 973:463-467.
15. Goumidi L., Flamant F., Lendon C., Galimberti D., Pasquier F., Scarpini E., Hannequin D., Campion D., Amouyel P., Lambert J.C., Meirhaeghe A. Study of thyroid hormone receptor alpha gene polymorphisms on Alzheimer's disease. Neurobiol. Aging 2009, (Electronic publication ahead of print). PUBMED 19427062.
16. Graham A.J., Ray M.A., Perry E.K., Jaros E., Perry R.H., Volsen S.G., Bose S., Evans N., Lindstrom J., Court J.A. Differential nicotinic acetylcholine receptor subunit expression in the human hippocampus. J. Chem. Neuroanat. 2003, 25:97-113.
17. Hamon M. Science Vision 2006, University of Maastricht.
18. Hansson A.C., Cintra A., Belluardo N., Sommer W., Bhatnagar M., Bader M., Ganten D., Fuxe K. Gluco- and mineralocorticoid receptor-mediated regulation of neurotrophic factor gene expression in the dorsal hippocampus and the neocortex of the rat. Eur. J. Neurosci. 2000, 12:2918-2934.
19. Hattori N., Shimura H., Kubo S., Wang M., Shimizu N., Tanaka K., Mizuno Y. Importance of familial Parkinson's disease and parkinsonism to the understanding of nigral degeneration in sporadic Parkinson's disease. J. Neural Transm. 2000, 101-116. Suppl.
20. Hosing V.G., Schirmacher A., Kuhlenbaumer G., Freitag C., Sand P., Schlesiger C., Jacob C., Fritze J., Franke P., Rietschel M., Garritsen H., Nothen M.M., Fimmers R., Stogbauer F., Deckert J. Cholecystokinin- and cholecystokinin-B-receptor gene polymorphisms in panic disorder. J. Neural Transm. 2004, 147-156. Suppl.
21. Iriuchijima N., Sato-Harada R., Takano M., Fujio K., Sato T., Goto F., Harada A. Reduced expression of kinase-associated phosphatase in cortical dendrites of MAP2-deficient mice. Biochem. Biophys. Res. Commun. 2005, 338:1216-1221.
22. Iwamoto Y., Morinobu S., Takahashi T., Yamawaki S. Single prolonged stress increases contextual freezing and the expression of glycine transporter 1 and vesicle-associated membrane protein 2 mRNA in the hippocampus of rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31:642-651.
23. Jimenez-Mateos E.M., Paglini G., Gonzalez-Billault C., Caceres A., Avila J. End binding protein-1 (EB1) complements microtubule-associated protein-1B during axonogenesis. J. Neurosci. Res. 2005, 80:350-359.
24. Joels M., Hesen W., de Kloet E.R. Mineralocorticoid hormones suppress serotonin-induced hyperpolarization of rat hippocampal CA1 neurons. J. Neurosci. 1991, 11:2288-2294.
25. Juszczak G.R., Sliwa A.T., Wolak P., Tymosiak-Zielinska A., Lisowski P., Swiergiel A.H. The usage of video analysis system for detection of immobility in the tail suspension test in mice. Pharmacol. Biochem. Behav. 2006, 85:332-338.
26. Juszczak G.R., Blaszczyk J., Sadowski B., Sliwa A.T., Wolak P., Tymosiak-Zielinska A., Lisowski P., Swiergiel A.H. Lipopolysaccharide does not affect acoustic startle reflex in mice. Brain Behav. Immun. 2008, 22:74-79.
27. Juszczak G.R., Lisowski P., Sliwa A.T., Swiergiel A.H. Computer assisted video analysis of swimming performance in a forced swim test: simultaneous assessment of duration of immobility and swimming style in mice selected for high and low swim-stress induced analgesia. Physiol. Behav. 2008, 95:400-407.
28. Kantor D.B., Chivatakarn O., Peer K.L., Oster S.F., Inatani M., Hansen M.J., Flanagan J.G., Yamaguchi Y., Sretavan D.W., Giger R.J., Kolodkin A.L. Semaphorin 5A is a bifunctional axon guidance cue regulated by heparan and chondroitin sulfate proteoglycans. Neuron 2004, 44:961-975.
29. Karst H., Karten Y.J., Reichardt H.M., de Kloet E.R., Schutz G., Joels M. Corticosteroid actions in hippocampus require DNA binding of glucocorticoid receptor homodimers. Nat. Neurosci. 2000, 3:977-978.
30. Keeley M.B., Wood M.A., Isiegas C., Stein J., Hellman K., Hannenhalli S., Abel T. Differential transcriptional response to nonassociative and associative components of classical fear conditioning in the amygdala and hippocampus. Learn. Mem. 2006, 13:135-142.
31. Kest B., Jenab S., Brodsky M., Sadowski B., Belknap J.K., Mogil J.S., Inturrisi C.E. Mu and delta opioid receptor analgesia, binding density, and mRNA levels in mice selectively bred for high and low analgesia. Brain Res. 1999, 816:381-389.
32. Kim S.J., Kim J.E., Ko B.H., Moon I.S. Carbofuran induces apoptosis of rat cortical neurons and down-regulates surface alpha7 subunit of acetylcholine receptors. Mol. Cells 2004, 17:242-247.
33. Kurumaji A., Ito T., Ishii S., Nishikawa T. Effects of FG7142 and immobilization stress on the gene expression in the neocortex of mice. Neurosci. Res. 2008, 62:155-159.
34. Lahiri D.K., Chen D., Vivien D., Ge Y.W., Greig N.H., Rogers J.T. Role of cytokines in the gene expression of amyloid beta-protein precursor: identification of a 5″-UTR-binding nuclear factor and its implications in Alzheimer's disease. J. Alzheimers Dis. 2003, 5:81-90.
35. Lappe-Siefke C., Goebbels S., Gravel M., Nicksch E., Lee J., Braun P.E., Griffiths I.R., Nave K.A. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat. Genet. 2003, 33:366-374.
36. Latonen L., Jarvinen P.M., Laiho M. Cytoskeleton-interacting LIM-domain protein CRP1 suppresses cell proliferation and protects from stress-induced cell death. Exp. Cell Res. 2008, 314:738-747.
37. Leong M.L., Maiyar A.C., Kim B., O'Keeffe B.A., Firestone G.L. Expression of the serum- and glucocorticoid-inducible protein kinase, Sgk, is a cell survival response to multiple types of environmental stress stimuli in mammary epithelial cells. J. Biol. Chem. 2003, 278:5871-5882.
38. Luca F., Kashyap S., Southard C., Zou M., Witonsky D., Di Rienzo A., Conzen S.D. Adaptive variation regulates the expression of the human SGK1 gene in response to stress. PLoS Genet. 2009, 5:e1000489.
39. Lutfy K., Sadowski B., Kwon I.S., Weber E. Morphine analgesia and tolerance in mice selectively bred for divergent swim stress-induced analgesia. Eur. J. Pharmacol. 1994, 265:171-174.
40. McEwen B.S., Gianaros P.J. Central role of the brain in stress and adaptation: links to socioeconomic status, health, and disease. Ann. N.Y Acad. Sci. 2010, 1186:190-222.
41. McGowan P.O., Kato T. Epigenetics in mood disorders. Environ. Health Prev. Med. 2008, 13:16-24.
42. Mei B., Li C., Dong S., Jiang C.H., Wang H., Hu Y. Distinct gene expression profiles in hippocampus and amygdala after fear conditioning. Brain Res. Bull. 2005, 67:1-12.
43. Minamoto S., Ikegame K., Ueno K., Narazaki M., Naka T., Yamamoto H., Matsumoto T., Saito H., Hosoe S., Kishimoto T. Cloning and functional analysis of new members of STAT induced STAT inhibitor (SSI) family: SSI-2 and SSI-3. Biochem. Biophys. Res. Commun. 1997, 237:79-83.
44. Moutsimilli L., Farley S., Dumas S., El Mestikawy S., Giros B., Tzavara E.T. Selective cortical VGLUT1 increase as a marker for antidepressant activity. Neuropharmacology 2005, 49:890-900.
45. Naeve G.S., Ramakrishnan M., Kramer R., Hevroni D., Citri Y., Theill L.E. Neuritin: a gene induced by neural activity and neurotrophins that promotes neuritogenesis. Proc. Natl Acad. Sci. USA 1997, 94:2648-2653.
46. Newton S.S., Collier E.F., Hunsberger J., Adams D., Terwilliger R., Selvanayagam E., Duman R.S. Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors. J. Neurosci. 2003, 23:10841-10851.
47. Okubo T., Harada S., Higuchi S., Matsushita S. Investigation of quantitative trait loci in the CCKAR gene with susceptibility to alcoholism. Alcohol. Clin. Exp. Res. 2002, 26:2S-5S.
48. Orsetti M., Di Brisco F., Canonico P.L., Genazzani A.A., Ghi P. Gene regulation in the frontal cortex of rats exposed to the chronic mild stress paradigm, an animal model of human depression. Eur. J. Neurosci. 2008, 27:2156-2164.
49. Panocka I., Marek P., Sadowski B. Inheritance of stress-induced analgesia in mice. Selective breeding study. Brain Res. 1986, 397:152-155.
50. Panocka I., Massi M., Lapo I., Swiderski T., Kowalczyk M., Sadowski B. Antidepressant-type effect of the NK3 tachykinin receptor agonist aminosenktide in mouse lines differing in endogenous opioid system activity. Peptides 2001, 22:1037-1042.
51. Petronis A. Epigenetics and bipolar disorder: new opportunities and challenges. Am. J. Med. Genet. C Semin. Med. Genet. 2003, 123C:65-75.
52. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:e45.
53. Piwien Pilipuk G., Galigniana M.D., Schwartz J. Subnuclear localization of C/EBP beta is regulated by growth hormone and dependent on MAPK. J. Biol. Chem. 2003, 278:35668-35677.
54. Price J.L., Drevets W.C. Neurocircuitry of mood disorders. Neuropsychopharmacology 2010, 35:192-216.
55. Reiche E.M., Nunes S.O., Morimoto H.K. Stress, depression, the immune system, and cancer. Lancet Oncol. 2004, 5:617-625.
56. Ressler K.J., Paschall G., Zhou X.L., Davis M. Regulation of synaptic plasticity genes during consolidation of fear conditioning. J. Neurosci. 2002, 22:7892-7902.
57. Reyes T.M., Walker J.R., DeCino C., Hogenesch J.B., Sawchenko P.E. Categorically distinct acute stressors elicit dissimilar transcriptional profiles in the paraventricular nucleus of the hypothalamus. J. Neurosci. 2003, 23:5607-5616.
58. Robinson M.J., Edwards S.E., Iyengar S., Bymaster F., Clark M., Katon W. Depression and pain. Front. Biosci. 2009, 14:5031-5051.
59. Sacharczuk M., Juszczak G., Sliwa A.T., Tymosiak-Zielinska A., Lisowski P., Jaszczak K., Pluta R., Lipkowski A., Sadowski B., Swiergiel A.H. Differences in ethanol drinking between mice selected for high and low swim stress-induced analgesia. Alcohol 2008, 42:487-492.
60. Sacharczuk M., Juszczak G., Swiergiel A.H., Jaszczak K., Lipkowski A.W., Sadowski B. Alcohol reverses depressive and pronociceptive effects of chronic stress in mice with enhanced activity of the opioid system. Acta Neurobiol. Exp. (Wars) 2009, 69:459-468.
61. Sacharczuk M., Lesniak A., Korostynski M., Przewlocki R., Lipkowski A., Jaszczak K., Sadowski B. A polymorphism in exon2 of the d-opioid receptor affects nociception in response to specific agonists and antagonists in mice selectively bred for high and low analgesia. Pain 2010, 149:506-513.
62. Sacharczuk M., Sadowski B., Jaszczak K., Lipkowski A.W., Swiergiel A.H. Opposite effects of alcohol in regulating stress-induced changes in body weight between the two mouse lines with enhanced or low opioid system activity. Physiol. Behav. 2010, 99:627-631.
63. Sandi C. Glucocorticoid involvement in memory consolidation. Rev. Neurol. 2003, 3:843-848.
64. Sandi C. Stress, cognitive impairment and cell adhesion molecules. Nat. Rev. Neurosci. 2004, 5:917-930.
65. Schaaf M.J., Hoetelmans R.W., de Kloet E.R., Vreugdenhil E. Corticosterone regulates expression of BDNF and trkB but not NT-3 and trkC mRNA in the rat hippocampus. J. Neurosci. Res. 1997, 48:334-341.
66. Segerstrom S.C., Miller G.E. Psychological stress and the human immune system: a meta-analytic study of 30years of inquiry. Psychol. Bull. 2004, 130:601-630.
67. Shindo S., Yoshioka N. Polymorphisms of the cholecystokinin gene promoter region in suicide victims in Japan. Forensic Sci. Int. 2005, 150:85-90.
68. Sinha R. Chronic stress, drug use, and vulnerability to addiction. Ann. NY Acad. Sci. 2008, 1141:105-130.
69. Smeitink J., van den Heuvel L., DiMauro S. The genetics and pathology of oxidative phosphorylation. Nat. Rev. Genet. 2001, 2:342-352.
70. Swiergiel A.H., Dunn A.J. Distinct roles for COX1 and COX2 in interleukin-1-induced behavioral changes. J. Pharmacol. Exp. Therap. 2002, 302:1031-1036.
71. Tordera R.M., Pei Q., Sharp T. Evidence for increased expression of the vesicular glutamate transporter, VGLUT1, by a course of antidepressant treatment. J. Neurochem. 2005, 94:875-883.
72. Tremolizzo L., Carboni G., Ruzicka W.B., Mitchell C.P., Sugaya I., Tueting P., Sharma R., Grayson D.R., Costa E., Guidotti A. An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability. Proc. Natl Acad. Sci. USA 2002, 99:17095-17100.
73. Verma R., Holmans P., Knowles J.A., Grover D., Evgrafov O.V., Crowe R.R., Scheftner W.A., Weissman M.M., DePaulo J.R., Potash J.B., Levinson D.F. Linkage disequilibrium mapping of a chromosome 15q25-26 major depression linkage region and sequencing of NTRK3. Biol. Psychiatry 2008, 63:1185-1189.
74. Wang J., Campbell I.L. Cytokine signaling in the brain: putting a SOCS in it?. J. Neurosci. Res. 2002, 67:423-427.
75. Weinberg A., Creed F. Stress and psychiatric disorder in healthcare professionals and hospital staff. Lancet 2000, 355:533-537.
76. Willner P., Towell A., Sampson D., Sophokleous S., Muscat R. Reduction of sucrose preference by chronic unpredictable mild stress and its restoration by a tricyclic antidepressant. Psychopharmacology (Berl.) 1987, 93:358-364.
77. Zhang Y., Chong E., Herman B. Age-associated increases in the activity of multiple caspases in Fisher 344 rat organs. Exp. Gerontol. 2002, 37:777-789.